Literature DB >> 18499817

Serum ischaemia-modified albumin increases in critical lower limb ischaemia.

A Gunduz1, A Mentese, S Turedi, S C Karahan, U Mentese, O Eroglu, S Turkmen, I Turan, U Ucar, R Russell, F Balaban.   

Abstract

BACKGROUND: Ischaemia is a common phenomenon in the pathogenesis of a wide range of medical and surgical conditions, including myocardial infarction, mesenteric vascular occlusion and compartment syndrome. Ischaemia modified albumin has been suggested as an aid to clinical decision making in various clinical settings. This study examines the usefulness of IMA in the diagnosis of limb ischaemia (LI).
METHODS: This case-controlled study was performed in the emergency department of Karadeniz Technical University Hospital, Turkey. 22 patients presenting to the emergency departments and definitively diagnosed with LI were enrolled in the study. A control group of 22 healthy volunteers served as a reference for biochemical parameters.
RESULTS: The mean serum IMA level for LI patients was 0.295 (SD 0.062) ABSU. The mean serum IMA level for control patients was 0.174 (SD 0.061) ABSU. There was a statistically significant difference between the mean LI patient and mean control patient IMA levels (p<0.0005). A ROC curve analysis reveals the relationship between sensitivity and specificity for IMA in limb ischaemia.
CONCLUSION: There is a significant increase in serum IMA in limb ischaemia. Furthermore, using a cutoff of 0.22 ABSU, ROC curve analysis shows that IMA is 81.8% sensitive and 81.8% specific 81.8% in patients with clinically severe lower limb ischaemia. Future studies would be needed to determine if IMA would be clinically useful in the diagnosis of subtle limb ischaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499817     DOI: 10.1136/emj.2007.051292

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  6 in total

1.  Molecular biomarkers in stroke diagnosis and prognosis.

Authors:  Matthew B Maas; Karen L Furie
Journal:  Biomark Med       Date:  2009-08-01       Impact factor: 2.851

2.  Ischemia-modified albumin levels in children with chronic liver disease.

Authors:  Murat Cakir; Suleyman Caner Karahan; Ahmet Mentese; Elif Sag; Umit Cobanoglu; Tugcin Bora Polat; Erol Erduran
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

3.  Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.

Authors:  Muhip Kanko; Sadan Yavuz; Can Duman; Tulay Hosten; Emin Oner; Turan Berki
Journal:  J Cardiothorac Surg       Date:  2012-01-05       Impact factor: 1.637

4.  The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor.

Authors:  Kadir Kirboga; Ayse V Ozec; Mustafa Kosker; Ayhan Dursun; Mustafa I Toker; Huseyin Aydin; Haydar Erdogan; Aysen Topalkara; Mustafa K Arici
Journal:  J Ophthalmol       Date:  2014-12-16       Impact factor: 1.909

Review 5.  Diagnosing acute compartment syndrome-where have we got to?

Authors:  Tristan E McMillan; William Timothy Gardner; Andrew H Schmidt; Alan J Johnstone
Journal:  Int Orthop       Date:  2019-08-29       Impact factor: 3.075

6.  Ischemia modified albumin: does it change during pneumoperitoneum in robotic prostatectomies?

Authors:  Serpil Ustalar Ozgen; Bora Ozveren; Meltem Kilercik; Ugur Aksu; Binnaz Ay; Ilter Tufek; Ali Riza Kural; Levent N Turkeri; Fevzi Toraman
Journal:  Int Braz J Urol       Date:  2016 Jan-Feb       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.